LOGIN
Click here to receive automatic email updates on the most recent developments of your favorite GGW topic.
Draft Human Rights Guidelines for Pharmaceutical Companies in relation to Access to Medicines
Category: Global Regulation, Human Security
Paul Hunt is the UN Special Rapporteur on the “right of everyone to the enjoyment of the highest attainable standard of physical and mental health.” On September 19, 2007, Mr. Hunt published draft Human Rights Guidelines for Pharmaceutical Companies in relation to Access to Medicines. The Draft Guidelines set forth a human rights regimen designed to pressure pharmaceutical companies to embrace a “right to health” the scope of which has never been established in international law. The Draft Guidelines call for: the adoption of corporate mission statements that expressly recognize and implement the “right to health;” the use by corporations of “human rights impact assessments” when formulating and implementing their corporate strategies, policies, programs, projects, and activities; the adoption of a governance system that makes Board members directly responsible and accountable for the corporation’s “access to medicines strategy;” and
the dilution of corporate intellectual property rights relating to medicines. To access the draft Guidelines, please click here.
Hunt, Paul, "Draft Human Rights Guidelines for Pharmaceutical Companies in relation to Access to Medicines," (2007)










